Abstract Rationale The immunity debt hypothesis suggests increased vulnerability to pathogens due to reduced exposure during the pandemic. One year after COVID-19 restrictions ended, influenza rates exceeded 130% in winter and summer. Viral airway injury may cause small airway lesions linked to physiological dysfunction. Small airway disease (SAD) involves bronchiole narrowing from inflammation, edema, or bronchoconstriction, causing persistent cough. Respiratory passages 2 mm are assessed through oscillometry, with R5-R20 as the primary parameter in Z-score formulas. This study aimed to determine SAD prevalence in post-viral cough (PVC) patients and compare Z-scores and cut-offs. Methods A descriptive cross-sectional study was conducted at a respiratory center on patients with post-viral cough between May 2024 and August 2025. Cough was categorized as acute, subacute, or chronic. SAD was assessed using PulmoScan Oscillometry per ERS guidelines, defined by R5-R20 0.07 kPa/(L/s) and Z-score 1.645; X5, AX, and Fres were included. FeNO was measured in some patients. Frequencies, percentages, and parametric/non-parametric statistics were used. McNemar’s test compared paired proportions, and Chi-square test was used. SPSS v30 was used with p 0.05 significance. Results PVC was diagnosed in 48.4% (n = 181) of patients. 64.6% were female, mean age 45.6 years (SD 24.9), BMI 25.9 kg/m2 (SD 5.8). Most reported acute (49.7%) or subacute (28.8%) cough. Influenza was most prevalent (28.6%, n = 35), and FeNO (n = 112) showed lower values in 86.6% of cases. SAD prevalence using cutoff was 60.2%, but 27.8% with z-score (p 0.001). In acute and subacute cough, SAD was observed in 67.1% and 60.8% versus 31.8% and 29.4% (p 0.05). Similar trends appeared for X5, AX, and Fres. No differences were found between viral diagnosis, sex, and FeNO values. Conclusions Oscillometry shows clinical value for post-viral cough patients. SAD prevalence was higher using cutoff values versus Z-scores. Research is needed to define Latin American population cutoff levels. Results could enable earlier use of small-particle bronchodilators/corticosteroids. This abstract is funded by: None
Calderon et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: